chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Cough, Feeling abnormal, Malaise, Respiratory disorder
Clinical narrative: Information has been received from a 74 year old male patient with cardiac disorder, sulfonamide, LEVAQUIN and mycin allergy who on 29-NOV-2010 was vaccinated with a 0.65 ml dose subcutaneously of ZOSTAVAX (Merck) (Lot # not reported). Concomitant therapy included influenza virus vaccine (unspecified), LIPITOR and aspirin (manufactured unspecified). The consumer reported that on 29-NOV-2010 while he was recovering from pneumonia he received the ZOSTAVAX (Merck) dose. He believed that he was recovered from pneumonia because he had finish with his antibiotic therapy and felt better. Then, 18 hours after receiving the vaccine, he started to experienced pneumonia-like symptoms such as coughing, yucky feeling and feeling sick. At the time of the report, the patient had not recovered. No laboratories were performed. The patient did not seek medical attention. No further information is available.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood test, Eye pruritus, Pruritus
Clinical narrative: Information has been received from a 72 year old female consumer with no pertinent medical history, no drug reactions/allergies, who on 14-NOV-2010 was vaccinated with a "1 time" dose of ZOSTAVAX (Merck) (Lot # not reported). Concomitant therapy included LIPITOR, PREMARIN and BENADRYL. Consumer stated that on 21-NOV-2010 she experienced itchiness in the eyes and head and asked if these symptoms could indicate shingles. A blood test was performed (results not provided). Consumer sought unspecified medical attention. At the time of the report the outcome of the patient was unknown. No further information is available.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Erythema, Local swelling, Pruritus
Clinical narrative: Information has been received from a 74 year old female consumer with penicillin allergy and allergic reactions to myocins, tetracycline, quinolones and CIPRO who on 11-DEC-2010, was vaccinated with a dose of ZOSTAVAX (Merck) (lot# not reported). Concomitant therapy included lisinopril (manufacturer unknown), "generic" NORVASC, generic simvastatin (MSD), metformin, timolol (manufacturer unknown) and steroids for the eye. It was reported that the consumer experienced a burning sensation when the shot was administered. The burning sensation went away but over the next several days a raised red spot developed that grew to the size of a 50 cent piece. The spot was itchy and was still present, although it had lightened in color somewhat. It was unknown if the patient sought medical attention. On an unspecified date, the consumer recovered from burning sensation. At the time of the report, the patient's spot itchy and raised red spot that grew to the size of a 50 cent piece persisted. Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site pain, Nerve injury, Oropharyngeal pain, Pyrexia
Clinical narrative: Information has been received from a 64 year old female with itching and allergies to pain medications, codeine and minocycline (reported as "monocyclene") and a history of hypothyroidism who in September 2010, was vaccinated SC with 0.65 ml, single dose of ZOSTAVAX (Merck), (lot # not reported). Concomitant therapy included BENADRYL and SYNTHROID. In the beginning of November 2010 (approximately 01-NOV-2010) the patient experienced "pain where she got the shot, a rash up and down her arm, throat pain, headache and a low grade fever." "Her doctor told that her rash was the result of a pinched nerve." Azithromycin (reported as "azithromyacin") was given for the treatment of throat pain. The patient did not recover at the time of report. No lab diagnostics studies performed. The patient sought unspecified medical attention. Additional information is not expected.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a 64 year old female with itching and allergies to pain medications, codeine and minocycline (reported as "monocyclene") and a history of hypothyroidism who in September 2010, was vaccinated SC with 0.65 ml, single dose of ZOSTAVAX (Merck), (lot # not reported). Concomitant therapy included BENADRYL and SYNTHROID. In the beginning of November 2010 (approximately 01-NOV-2010) the patient experienced "pain where she got the shot, a rash up and down her arm, throat pain, headache and a low grade fever." "Her doctor told that her rash was the result of a pinched nerve." Azithromycin (reported as "azithromyacin") was given for the treatment of throat pain. The patient did not recover at the time of report. No lab diagnostics studies performed. The patient sought unspecified medical attention. Additional information is not expected.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Information has been received from a 60 year old female patient with hypothyroidism, hypertension, hypercholesterolaemia and acid reflux and no drug reactions or allergies who on 10-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # and route not reported). Concomitant therapy included simvastatin (manufacturer unknown), captopril, SYNTHROID and ACIPHEX. The consumer reported that on 11-NOV-2010 she developed a fever and chills. She said that "she could not get warm, though she was covered with blankets". She also reported a mild headache. The patient denied any injection site pain, swelling or redness. She said that on 13-DEC-2010 she was fully recovered and she "felt fine". The patient did not seek medical attention. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site pain
Clinical narrative: Information has been received from a female consumer who was vaccinated with a dose of ZOSTAVAX (Merck) on 02-NOV-2010. On 02-NOV-2010, the patient experienced a lump at the injection site, which was painful. Additional information has been requested.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Joint swelling, Local swelling
Clinical narrative: Information has been received from a physician concerning an 82 year old male with Parkinson's Disease, Carpal Tunnel Syndrome and steroids allergy and a history of hives while taking penicillin (unspecified) and rash while taking BACTRIM who on 21-DEC-2010 was subcutaneously vaccinated with a dose of ZOSTAVAX (Merck) (lot # 664275/0960Y) into left arm. Concomitant therapy included aspirin, LIPITOR, NEXIUM and carbidopa/levodopa (MSD). On 22-DEC-2010 the patient woke with swelling in his left wrist over his thumb. At the time of reporting, the patient had not recovered and would see his internist on 23-DEC-2010. No lab diagnostics studies were performed. The patient sought unspecified medical attention. Follow up information has been received from a physician concerning an 82 year old male with Parkinson's Disease, Carpal Tunnel Syndrome in both wrists who on 21-DEC-2010 was subcutaneously vaccinated with the first dose of ZOSTAVAX (Merck) (lot # 664275/0960Y) into left arm. On 22-DEC-2010 in the morning the patient woke with swelling in his left wrist over his thumb (radial aspect). None tender and it was not treatment reporter, gradually resolved. At the time of reporting, the patient recovered from swelling in his left wrist over his thumb. Additional information is not expected.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Genital herpes, Skin exfoliation
Clinical narrative: Information has been received from a 65 year old female patient with pertinent medical history of SYNTHROID used and adverse drug reaction to TEQUIN, who on 06-DEC-2010 was vaccinated with ZOSTAVAX (Merck) (lot # not reported). There was no concomitant medication. The patient stated that she developed scaly skin and vaginal herpes in December 2010 after she was given ZOSTAVAX (Merck). It was reported that the patient had unspecified labs/diagnostics tests. At the time of reporting, the outcome of the events was not reported. The patient sought unspecified medical attention. No further information is available.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Neurological symptom, Rash
Clinical narrative: Information has been received from a physician concerning a 61 year old male with thyroid disorder and gastrooesophageal reflux who on 14-DEC-2010 was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Concomitant therapy included PREVACID and SYNTHROID. Subsequently the patient developed shingles after administration of ZOSTAVAX (Merck). Specifically, a rash developed 1 week after vaccination on 21-DEC-2010, then on 04-JAN-2010 the patient visited the physician office and showed classic symptoms of shingles with left flank abdominal rash and neuropathic symptoms. The patient did not recover. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 62 year old female who on 16-DEC-2010 was vaccinated with ZOSTAVAX (Merck). Then (on 16-DEC-2010) an injection site reaction occurred 24 hours after which was red and size of a baseball and lasted for 3 days. The patient was given ADVIL treatment. On 20-DEC-2010 the patient recovered. The patient did not seek medical attention. Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Swelling
Clinical narrative: Information has been received from a 63 year old male with no drug reaction/allergies and no pertinent medical history, who on 23-DEC-2010 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# not reported). There was no concomitant medication. On 25-DEC-2010 "two days after vaccination" the patient experienced swelling. No diagnostic laboratory tests were performed. The patient's swelling persisted. The patient did not seek medical attention. This is one of several reports received from the same source. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a 13 year old patient who on 28-DEC-2010 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# not reported) instead of VARIVAX (Merck) for the treatment of chickenpox. The patient did not seek medical attention. Follow-up information was received via telephone call from a nurse who stated that it was a case of the wrong product was grabbed off the shelf by mistake. She also stated that it was not a case of product confusion. Additional information is not expected.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Injection site reaction, Injection site warmth, Rash erythematous
Clinical narrative: Information has been received from a registered pharmacist concerning a 78 year old female with no drug reaction/allergies and no pertinent medical history, who on 22-DEC-2010 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) lot # 669535/1506Z). There was no concomitant medication. On approximately 22-DEC-2010 "within 24 hours after vaccination" the patient experienced pruritis and warmth at the injection site. On 28-DEC-2010 the patient called the pharmacy stating she had small red spots resembling chicken pox that were not blistered. No diagnostic laboratory tests were performed. At the time of the report, the patient's status was not recovered. The patient sought unspecified medical attention. VZVIP offered to the pharmacist but the spots were not open. Follow-up information was received from a registered pharmacist concerning a 78 year old female with penicillin, sulfa and LEVAQUIN allergies and no illness at the time of vaccination, who on 22-DEC-2010 at 1:00 PM was vaccinated subcutaneously in her left arm with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669535/1506Z). On 25-DEC-2010 the patient experienced warmth, red, 3 pinic red bumps with no blisters at the injection site lasted a few weeks. At the time of the report, the patient's status was recovered. Additional information is not expected.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Back pain, Erythema, Groin pain, Injection site inflammation
Clinical narrative: Information has been received from a 63 year old female consumer with "Flaxseed, aspirin, and unspecified dye" allergies and no pertinent medical history, who on 23-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# not reported). Concomitant therapy included ADVIL. The consumer stated that while on ZOSTAVAX (Merck), on 25-DEC-2010 the patient experienced terrible muscle pull in her groin and had rash on her right arm for that day. On 25-DEC-2010 she took ADVIL because she was going out for that day. On 26-DEC-2010 she had really bad aches in her hip and pains in her upper back, the groin thing was less and the injection site became inflamed. On 27-DEC-2010 she was much better. All of the symptoms other that her arm being red had gone away. There were no laboratories diagnostics performed. The patient did not seek medical attention. Follow-up information has been received from the patient who reported that symptoms occurred 24 to 48 hours after the she was vaccinated with ZOSTAVAX (Merck). Follow-up information has been received which reported that the patient had stated on 04-JAN-2011 regarding her vaccination with a dose of ZOSTAVAX (Merck) (Lot#669588/1452Z), SQ, Left arm, on 23-DEC-2010, unknown time. It was reported that on 23-DEC-2010 that the patient experienced red, hot to touch, itching, groin and hip pain. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscle strain, Pruritus, Rash, Skin warm
Clinical narrative: Information has been received from a 63 year old female consumer with "Flaxseed, aspirin, and unspecified dye" allergies and no pertinent medical history, who on 23-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# not reported). Concomitant therapy included ADVIL. The consumer stated that while on ZOSTAVAX (Merck), on 25-DEC-2010 the patient experienced terrible muscle pull in her groin and had rash on her right arm for that day. On 25-DEC-2010 she took ADVIL because she was going out for that day. On 26-DEC-2010 she had really bad aches in her hip and pains in her upper back, the groin thing was less and the injection site became inflamed. On 27-DEC-2010 she was much better. All of the symptoms other that her arm being red had gone away. There were no laboratories diagnostics performed. The patient did not seek medical attention. Follow-up information has been received from the patient who reported that symptoms occurred 24 to 48 hours after the she was vaccinated with ZOSTAVAX (Merck). Follow-up information has been received which reported that the patient had stated on 04-JAN-2011 regarding her vaccination with a dose of ZOSTAVAX (Merck) (Lot#669588/1452Z), SQ, Left arm, on 23-DEC-2010, unknown time. It was reported that on 23-DEC-2010 that the patient experienced red, hot to touch, itching, groin and hip pain. Additional information has been requested.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Hyperaesthesia
Clinical narrative: Information has been received from a 76 year old female who in approximately July 2009, was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck). Concomitant therapy included pain medications. In approximately October 2010, the patient experienced a mild-case of shingles. The patient sought unspecified medical attention. She reported that she had shingles for about 24 hours and it went away (also reported as recovered about a month ago, in approximately November 2010). Follow-up information has been received from a licensed practical nurse concerning the 76 year old female with a history of chickenpox at age 5, who on 21-OCT-2009, at 14:39, was vaccinated SC with a 0.5 ml dose of ZOSTAVAX (Merck) into her left arm. On 04-OCT-2010 the patient visited office and described 2 day history of sensitivity on the right T11/T12. The physician's assessment was shingles. The patient was prescribed valacyclovir hydrochloride 1 g three times a day for 7 days and LYRICA 75mg three times a day for 30 days. On 10-NOV-2010, the patient recovered. It was stated that recently there was no exposure to chickenpox or herpes zoster. No further information is available.
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Herpes zoster ophthalmic
Clinical narrative: Information has been received from a female with a history of shingles about 10 years ago who in approximately June 2010, about 6 months ago, was vaccinated with a dose of ZOSTAVAX (Merck). In approximately June 2010, since receiving the vaccine, the patient had gotten more outbreaks of shingles that affect her right eye. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. No further information is available.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Blood test
Clinical narrative: Information has been received from a 62 year old female patient with high cholesterol and a history of thyroid disorder and no drug reactions/allergies who on 20-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (lot number unknown). Concomitant therapy included LEVOXYL, simvastatin (manufacturer unknown), calcium (unspecified), estrogens (unspecified) (reported as hormone replacement), ubidecarenone (reported as coQ10), vitamins (unspecified) (reported as "multivitamin") and omega-3 marine triglycerides (reported as fish oil). On 26-DEC-2010 the patient had broken out in one blister on abdomen. The patient wanted to know how long she needed to stay away from her grandchildren once she received ZOSTAVAX (Merck) shot and also how she should treat the blister on her abdomen. Laboratory test blood work was performed, no results provided. The patient did not seek medical attention. There was no treatment given for the adverse event. The patient's blister on abdomen persisted. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Herpes zoster, Neck pain, Rash vesicular
Clinical narrative: Information has been received from a physician assistant concerning a 72 year old female with drug allergies to codeine, penicillin and FLAGYL and no medical history, who on 14-SEP-2009 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 664634/0742Y, expired date 23-NOV-2010). Concomitant therapy included "thyroid", calcium, aspirin and EVISTA. On 22-DEC-2010 the patient experienced pain and burning followed by a vesicular rash on the left side of her neck toward deltoid area of shoulder. The patient was seen in the office on 28-DEC-2010, diagnosis shingles. Treatment given for this AE included VALTREX 1 GM three times a day. No lab diagnostics studies performed. At the time of reporting, the patient's status was not recovered. Additional information has been requested.
Age: 89.0
Sex: F
Vaccine: VARZOS
Symptoms: Eye irritation, Eye pruritus, Lacrimation increased
Clinical narrative: Information has been received from an 89 year old female patient with blood pressure high an no drug reactions or allergies, and a history of open heart surgery 10 years ago in December 2000, who in approximately July 2010 ("about 5 months ago"), was vaccinated with a single 0.65 ml dose of ZOSTAVAX (Merck) (lot # not reported) subcutaneously at one time. Concomitant therapy included high blood pressure medication (unspecified), atenolol (manufacturer unspecified, also reported as "tenanol") and PLAVIX. The patient advised that she received ZOSTAVAX (Merck) in approximately July 2010 ("about 5 months ago"), ever since had watery eyes and itching and burning in her right eye. There was no treatment given. At the time of the report, the patient's watery eyes and itching and burning in her right eye. The patient did not seek medical attention. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (lot number unspecified). On an unspecified date the patient developed zoster. It was unspecified if the patient sought medical attention. At the time of reporting, the patient's outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient (it was no reported if the patient was a child or an adult), who on 06-JAN-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # and route not reported) instead of receiving a dose of VARIVAX (Merck). No symptoms reported. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning an adult patient with a history of chickenpox in the past but her titers still being negative after having the disease who on 06-JAN-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot number 669408/1384Z, expiring on 19-JAN-2012) instead of the second dose of VARIVAX (Merck) (MSD). The patient had received a first dose of VARIVAX (Merck) on 11-NOV-2010. No adverse effect reported. It was unspecified if the patient sought medical attention. Follow up information has been received from the registered nurse stated that it was a case of the wrong product was pulled off the shelf by mistake. It was not a case of product confusion. Additional information is not expected.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Nausea, Pain, Pruritus
Clinical narrative: Information has been received from a medical professional concerning a 76 year old female patient, who on 07-APR-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # 664090/0139Y) SQ. The medical professional reported that on 01-JAN-2011 the patient went to the emergency room, but was not admitted to the hospital, with a case of shingles. While at the emergency room the patient received acyclovir and hydrocodone of unspecified doses. On 05-JAN-2011 the physician indicated that the patient had eruptions on the left lower quadrant descending down the left lower back which were identified as shingles. On 05-JAN-2011 the physician discontinued the two preceding medications acyclovir and hydrocodone and put the patient on VALTREX, PHENERGAN and LYRICA. At the time of the report, the patient was recovering. Additional information has been received from a physician, medical records and questionnaire concerning a 76 year old female who on 07APR2009 at 10:53 AM was vaccinated with ZOSTAVAX (Merck) (Lot # 664090/0139Y) SQ left upper arm. No rash occurred at the site of injection or elsewhere within 42 days of vaccination. On 01JAN11, she presented to ER with pain and a moderate rash, described as zoster, on the posterior aspect of the lateral abdomen, anterior aspect of left lateral abdomen and left lower quadrant. The quality of the pain described as aching and stabbing which began four days ago. Rash described as erythematous, vesicular (also described by the patient as "red raised rash with blisters") that began three days ago. Pt complaining of pain and itching in areas of rash. It was reported that the patient had history of sulfa, erythromycin and stadol allergy, scoliosis, chronic bronchitis, asthma, osteoporosis, mitral valve prolapse, rapid heart rate and past surgical history bladder suspension, hysterectomy and appendectomy (onset dates not reported). Current medications include: magnesium oxide, CITRUCEL fiber laxative daily, alendronate (MSD) weekly, simvastatin (MSD), ADVAIR diskus, SYNTHROID, lisinopril-hydrochlorothiazide (manufacturer unknown) and metoprolol. Patient stable, diagnosis was made of shingles and the patient discharged with prescriptions for NORCO (5-325mg tablet prn q. six hours) and ZOVIRAX (800mg, 5 times /day x 10 days) and she was to follow up with her physician in 3-4 days. On 03JAN2011 office visit exam: patient with severe shingles left side, large eruption LLQ but extended down abdomen and to mid back. Patient denied pain. It was noted that patient experienced nausea and vomiting caused by acyclovir and hydrocodone. Acyclovir was discontinued and prescriptions were given for VALTREX and promethazine HCL. It was noted that if hydrocodone causes more nausea, it would be changed to LYRICA. All available medical records will be provided upon request. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Rash vesicular, Vomiting
Clinical narrative: Information has been received from a medical professional concerning a 76 year old female patient, who on 07-APR-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # 664090/0139Y) SQ. The medical professional reported that on 01-JAN-2011 the patient went to the emergency room, but was not admitted to the hospital, with a case of shingles. While at the emergency room the patient received acyclovir and hydrocodone of unspecified doses. On 05-JAN-2011 the physician indicated that the patient had eruptions on the left lower quadrant descending down the left lower back which were identified as shingles. On 05-JAN-2011 the physician discontinued the two preceding medications acyclovir and hydrocodone and put the patient on VALTREX, PHENERGAN and LYRICA. At the time of the report, the patient was recovering. Additional information has been received from a physician, medical records and questionnaire concerning a 76 year old female who on 07APR2009 at 10:53 AM was vaccinated with ZOSTAVAX (Merck) (Lot # 664090/0139Y) SQ left upper arm. No rash occurred at the site of injection or elsewhere within 42 days of vaccination. On 01JAN11, she presented to ER with pain and a moderate rash, described as zoster, on the posterior aspect of the lateral abdomen, anterior aspect of left lateral abdomen and left lower quadrant. The quality of the pain described as aching and stabbing which began four days ago. Rash described as erythematous, vesicular (also described by the patient as "red raised rash with blisters") that began three days ago. Pt complaining of pain and itching in areas of rash. It was reported that the patient had history of sulfa, erythromycin and stadol allergy, scoliosis, chronic bronchitis, asthma, osteoporosis, mitral valve prolapse, rapid heart rate and past surgical history bladder suspension, hysterectomy and appendectomy (onset dates not reported). Current medications include: magnesium oxide, CITRUCEL fiber laxative daily, alendronate (MSD) weekly, simvastatin (MSD), ADVAIR diskus, SYNTHROID, lisinopril-hydrochlorothiazide (manufacturer unknown) and metoprolol. Patient stable, diagnosis was made of shingles and the patient discharged with prescriptions for NORCO (5-325mg tablet prn q. six hours) and ZOVIRAX (800mg, 5 times /day x 10 days) and she was to follow up with her physician in 3-4 days. On 03JAN2011 office visit exam: patient with severe shingles left side, large eruption LLQ but extended down abdomen and to mid back. Patient denied pain. It was noted that patient experienced nausea and vomiting caused by acyclovir and hydrocodone. Acyclovir was discontinued and prescriptions were given for VALTREX and promethazine HCL. It was noted that if hydrocodone causes more nausea, it would be changed to LYRICA. All available medical records will be provided upon request. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: Information has been received from a doctor of pharmacy concerning a patient who on an unknown date, was vaccinated subcutaneaously with a 0.65 ml dose of ZOSTAVAX (Merck). On an unknown date, the patient developed a swollen knot at the injection site. On 07-JAN-2011, the patient recovered from swollen knot at injection site. The patient did not seek medical attention. Follow up information received from reporter doctor of pharmacy concerning a female patient with no illness at the time of vaccination, who on 28-DEC-2010 at 11:00am, was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # 665522/1765Y, expire date not reported), subcutaneously in the left arm. Doctor of pharmacy stated that on 28-DEC-2010 afternoon, the patient's injection site on upper left arm grew to be the size of a tennis ball and was itchy for 2-3 days. Doctor of pharmacy added that on 01-JAN-2011, the patient had recovered. No diagnostic/laboratory tests were performed. Additional information is not expected.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus, Rash, Skin warm
Clinical narrative: Information has been received from an approximately 61 year old female patient who on an unspecified date, was vaccinated with ZOSTAVAX (Merck) (lot# not reported). Subsequently the patient was experiencing a red, itchy lump at the injection site of ZOSTAVAX (Merck) and also had a rash with hot sensation. At the time of reporting, the outcome of the events was not reported. It was unspecified if the patient sought medical attention. No further information is available.
Age: 86.0
Sex: M
Vaccine: VARZOS
Symptoms: Adverse drug reaction, Condition aggravated, Pruritus, Skin ulcer, Vision blurred
Clinical narrative: Information has been received from an 87 year old male patient with eye disorder, "heart case" and "a certain sense to Algerian ivy" who in the middle of September 2010, was vaccinated with ZOSTAVAX (Merck) (lot# not reported) intramuscularly at one time. Concomitant therapy included XALATAN for eyes. The patient reported that he had shingles in August 2010 where he broke out in sores and had an itch on the right side above his hip up to the nipple. On 15-DEC-2010 the patient had sores again and an itch, but this time around his hips, above the nipple and on his back and waist. The patient also reported that XALATAN gave him blurry vision but he still used it. The patient "just came off anemia study" and the result was not reported. At the time of reporting, the outcome of the events was not reported. The patient was given no treatment and sought unspecified medical attention. No further information is available.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Rash, Skin ulcer
Clinical narrative: Information has been received from a 74 year old female with no drug reaction/allergies arthritis, heart problems and a history of shingles several years ago who in approximately 2006 "approximately 5 years ago" asked her doctor to give her a first dose of ZOSTAVAX (Merck) (dose, route and lot # not reported). Concomitant therapy included heart medication. In approximately November 2010 "about 2 months ago" the patient started having shingles symptoms again. The patient went to her doctor to see if it was definitely shingles, and he said he didn't know what it was. He gave the patient a cream, but he would not explain to her what it was or what it was for. The rash came and went with this cream, but it was nasty. The pain was severe and it literally had created what looked like a hole in her leg. That section had healed quite a bit, but the rash was nonetheless damaging other areas. The patient went to her pharmacist to ask him about getting another vaccine. No diagnostic laboratory tests were performed. At the time of the report, the patient's status was not recovered. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Information has been received for a pharmacist concerning a 70 year old female with a history of rheumatoid arthritis who on 07-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot # not reported). The patient had a bunch of concomitant medications, too many to provide at that time. The patient had been complaining of intermittent pain at the site of the injection. The patient did not know exactly how soon after the injection the pain started. The patient had not seen her physician and sought unspecified medical attention. At the time of the report, the patient's status was not recovered. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Information has been received from a nurse concerning a female who on 21-SEP-2009 was vaccinated SC with 0.5 ml dose of ZOSTAVAX (Merck) (lot # 664634/0742Y). On 07-JAN-2011 the patient experienced a vesicular rash on her right leg that appeared to be herpes zoster. The outcome of vesicular rash on her right leg was unknown. The patient was given TYLENOL and FAMVIR (also reported as MAVIR). The patient sought unspecified medical attention. No  further information is available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a nurse concerning a female who on 10-JUL-2009 was vaccinated SC with one dose of ZOSTAVAX (Merck) (lot # not reported) in a healthcare facility. On 22-NOV-2010 the patient experienced shingles. The outcome of shingles was unknown. Unspecified treatment was given to the patient. The patient sought unspecified medical attention. No further information is available.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a medical assistant concerning a 70 year old male with hypertension and thyroid disorder who on 03-SEP-2008 was subcutaneously vaccinated with a 0.65ml dose of ZOSTAVAX (Merck) (lot# 659615/0162X). The patient took unspecified medicines to treat hypertension and thyroid diseases. On approximately 10-DEC-2010 (3 to 5 days before 15-DEC-2010), the patient developed shingles. On 15-DEC-2010 the patient was given a second dose of ZOSTAVAX (Merck) (lot# not reported). The patient also saw an ophthalmologist for his symptoms. At the time of reporting, the outcome was unknown. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Oropharyngeal pain, Rash
Clinical narrative: Information has been received from a 76 year old female with drug reaction to sulfa and a history of mastectomy and reconstructive surgery (in 1998) who in May 2008, was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Concomitant therapy included ADVAIR and blood pressure pills. On 03-JUL-2010 the patient broke out with shingles. The patient also reported a sore throat along with blisters and bumps all along her arm. Unspecified medical attention was sought and there was no laboratory test performed. Additional information has been requested.
Age: 84.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Alopecia, Condition aggravated, Herpes zoster, Skin exfoliation
Clinical narrative: Information has been received from an 84 year old female with shell fish allergy and a history of shingles (approximately in June 2006) who on 17-JUN-2009 was vaccinated with ZOSTAVAX (Merck) (lot# not reported). On approximately 08-JUL-2009 (also reported as three weeks after receiving vaccine) the patient developed shingles. She stated her body broke out, she lost hair and her palms also broke out and her skin peeled off. The consumer also mentioned that she developed shingles three year before receiving the vaccine and received ZOSTAVAX (Merck) to prevent  a reoccurrence. Unspecified medical attention was sought. It was "not sure" if there was laboratory test performed.  At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 84.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Ecchymosis, Pruritus, Serum sickness-like reaction
Clinical narrative: Information has been received from an 84 year old female with shell fish allergy and a history of shingles (approximately in June 2006) who on 17-JUN-2009 was vaccinated with ZOSTAVAX (Merck) (lot# not reported). On approximately 08-JUL-2009 (also reported as three weeks after receiving vaccine) the patient developed shingles. She stated her body broke out, she lost hair and her palms also broke out and her skin peeled off. The consumer also mentioned that she developed shingles three year before receiving the vaccine and received ZOSTAVAX (Merck) to prevent  a reoccurrence. Unspecified medical attention was sought. It was "not sure" if there was laboratory test performed.  At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 84.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Alopecia, Condition aggravated, Herpes zoster, Skin exfoliation
Clinical narrative: Information has been received from a physician concerning an 84 year old female patient with hypertension, hypothyroidism and codeine, penicillin and shrimp allergies who on 17-JUN-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot number unknown). Concomitant therapy included EVISTA, DIOVAN, NEURONTIN and SYNTHROID. The physician stated that on approximately 08-JUL-2009 "about three weeks later", the patient developed a delayed serum sickness reaction. Itching and ecchymosis had been noted since that time. The patient was sent to a dermatologist and was given ATARAX and ointments (Therapy unspecified) that helped but not resolved the itching. The physician described the ecchymosis to be "massive" on the patient's arms and legs. No laboratory studies were performed. The patient had not recovered from serum sickness reaction, itching and ecchymosis. Additional information has been requested.
Age: 84.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Ecchymosis, Pruritus, Serum sickness-like reaction
Clinical narrative: Information has been received from a physician concerning an 84 year old female patient with hypertension, hypothyroidism and codeine, penicillin and shrimp allergies who on 17-JUN-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot number unknown). Concomitant therapy included EVISTA, DIOVAN, NEURONTIN and SYNTHROID. The physician stated that on approximately 08-JUL-2009 "about three weeks later", the patient developed a delayed serum sickness reaction. Itching and ecchymosis had been noted since that time. The patient was sent to a dermatologist and was given ATARAX and ointments (Therapy unspecified) that helped but not resolved the itching. The physician described the ecchymosis to be "massive" on the patient's arms and legs. No laboratory studies were performed. The patient had not recovered from serum sickness reaction, itching and ecchymosis. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a pharmacist concerning a 62 year old female with no relevant medical history or allergies who on 07-JUL-2010 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot number 665531/0698Z). There was no concomitant medication. On 09-JUL-2010 the patient called the pharmacist to report that "yesterday" (08-JUL-2010) she noted that the area at the injection site was red and swollen. The patient reported that she put ice intermittently on the red and swollen site. The pharmacist stated that she or the patient's doctor could be contacted but patient had not seen the doctor regarding this matter. The pharmacist recommended that patient to come to see her on 09-JUL-2010. The patient's events persisted. Additional information has been requested.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic, Rash vesicular
Clinical narrative: Information has been received from a pharmacist concerning a 79 year old female with no known drug allergies who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). Subsequently the patient experienced a varicella-like rash on her arms, legs and trunk a few days after receiving ZOSTAVAX (Merck). The patient described the rash as raised bumps that are itchy. Unspecified medical attention was sought. No lab test was performed. The patient was recovering from the events. Additional information has been requested.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Dizziness, Gait disturbance, Headache, Pain
Clinical narrative: Information has been received from a 76 year old female who on 06-JUL-2010 was vaccinated with ZOSTAVAX (Merck) (Lot # unknown). The patient stated that on 06-JUL-2010, a few hours after receiving ZOSTAVAX (Merck) she started feeling body pains, dizziness, headache and difficulty walking. The patient sought unspecified medical attention. At the time of this report, the patient was recovering. Follow up information has been received which reported that on 06-JUL-2010, at 10:55, the 76 year old female patient was vaccinated with the first dose of ZOSTAVAX (Merck) (Lot # 665514/0145Z) into the left deltoid. It was reported that the patient never reported reactions. Follow up information has been received from the consumer who stated that she did not feel that her symptoms were related to ZOSTAVAX (Merck). She had had these type of symptoms for years. Additional information is not expected.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a 65 year old male with no allergies, blood pressure and cholesterol, who in 2009 was vaccinated with ZOSTAVAX (Merck). Concomitant medications included hydrochlorothiazide (+) lisinopril and LIPITOR. On 06Jul2010, the patient reported he now has shingles. No diagnostic laboratory studies were performed. The patient sought unspecified medical attention. Follow up information has been received indicating that the patient's adverse event was that he developed herpes zoster despite being vaccinated for it several months earlier. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint injury
Clinical narrative: Information has been received from a pharmacy technician concerning a 62 year old female patient who on 09-FEB-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # 669264/1363Z, Exp date 15-JAN-2012, route not reported). The pharmacy technician stated that on an unspecified date, the patient injured her lip after ZOSTAVAX (Merck) was administered. The patient was treated with MEDROL dose pack. At the time of the report, the patient had not recovered. No further information is available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning her mother who on an unspecified date was vaccinated SQ with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot# unknown). The physician reported that her mother got ZOSTAVAX (Merck) and on an unspecified date got shingles. The time frame from when the patient began taking ZOSTAVAX (Merck) to getting shingles was unspecified. At the time of the report, the patient was recovering from shingles. The patient sought unspecified medical attention. No further information is available.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Diarrhoea, Nausea
Clinical narrative: Information has been received from a Doctor of Pharmacy concerning a 72 year old male patient who on 09-NOV-2010 was vaccinated with a dose of PNEUMOVAX 23 (lot #, expire date and route not reported) and then, on 15-NOV-2010 the patient was vaccinated with a dose of ZOSTAVAX (Merck) (lot # 664670/0151Z, expire date 28-AUG-2011, route not reported). There was no concomitant medication. On 15-NOV-2010, within 1 hour after receiving ZOSTAVAX, the patient developed diarrhea, also nausea and stomach pains that evening. Subsequently, the patient recovered from developed diarrhea, nausea and stomach pains on 16-NOV-2010. The patient sought medical attention by calling to the pharmacy. Follow up information has been received from the physician reporting that the patient experienced diarrhea one hour after vaccination with a dose of ZOSTAVAX (Merck). No further information is available.
Sex: F
Vaccine: VARZOS
Symptoms: Laryngitis, Oropharyngeal pain
Clinical narrative: Information has been received from a female patient who on 14-JUN-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (lot# not reported). The patient reported that after receiving ZOSTAVAX (Merck) she had been experiencing laryngitis and a sore throat. It is unknown if the patient sought medical attention. At the time of the report, the outcome of the patient was unknown. No further information is available.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered pharmacist concerning a 76 year old female patient with no pertinent medical history or drug reactions/allergies who on 10-AUG-2010 was vaccinated SC with a "standard dose" of ZOSTAVAX (Merck) (Lot number 665525/0695Z, ex 28-APR-2011). Concomitant therapies included: PLAVIX, simvastatin (manufacturer unknown), oxybutynin (manufacturer unknown), ranitidine (manufacturer unknown) and levothyroxine sodium (manufacturer unknown). In August 2010 after getting ZOSTAVAX (Merck), the patient developed an injection site reaction. The site was red, warm and round. The patient sought medical attention by seeing pharmacist. There was no lab diagnostic test performed. At the time of report the patient's status was recovering. Follow up information has been received from the registered pharmacist concerning the 76 year old female patient with aspirin allergy, hypothyroidism and hypercholesterolemia who on 10-AUG-2010 at 09:20 was vaccinated SC in the left arm with a dose of ZOSTAVAX (Merck) (lot number 665525/0695Z). On 11-AUG-2010 at 09:00 the patient developed small red, slightly firm, oblong patch, warm and slightly elevated. No pain or discomfort or fever. The symptoms went away 4 to 5 days later. Patient felt remarkable. The patient recovered on 14-AUG-2010. Additional information is not expected.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Information has been received from a pharmacist concerning a 63 year old female patient with no pertinent medical history and no allergies who on 10-AUG-2010 was vaccinated subcutaneously with a 0.65ml dose of ZOSTAVAX (Merck) (lot#665525/0695Z). Concomitant therapy included low dose aspirin. It was reported that the patient developed an injection site reaction after getting ZOSTAVAX (Merck). It was red, warm and round. It was initially itchy but not anymore. The size of the reaction was about the size of a "quarter" but now it's the size of a silver dollar. The patient saw the pharmacist to seek medical attention. There were no laboratory diagnostics studies performed. At the time of this report, the patient was recovering. Additional information has been requested.